Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants

@inproceedings{Harkins2015DevelopmentOA,
  title={Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants},
  author={Kristin A Harkins and Pamela L Sankar and Reisa A. Sperling and Joshua D Grill and Robert C Green and Keith A. Johnson and Megan E Healy and Jason H. T. Karlawish},
  booktitle={Alzheimer's Research & Therapy},
  year={2015}
}
The objective of this study was to develop a process to maximize the safety and effectiveness of disclosing Positron Emission Tomography (PET) amyloid imaging results to cognitively normal older adults participating in Alzheimer’s disease secondary prevention studies such as the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) Study. Using a modified Delphi Method to develop consensus on best practices, we gathered and analyzed data over three rounds from experts in two relevant… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS
17 Citations
25 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Testing the use of standardized scripts for disclosing ‘hypothetical/mock’ amyloid PET scan results to nondemented cognitively impaired patients and their care partners [abstract

  • M Witte, J Barnes, J Lingler, M Agronin, H Hochstetler, K Healey
  • Alzheimers Dement. 2013;9:131–P132. Harkins et…
  • 2015
2 Excerpts

Disclosing amyloid imaging results in MCI: what do patients and families want, and why? [abstract

  • J Lingler, S Roberts, M Butters, P Lisa, R Schulz, L Hu
  • Alzheimers Dement. 2013;9:533–P534
  • 2013
2 Excerpts

Similar Papers

Loading similar papers…